本頁面由Tiger Trade Technology Pte. Ltd.提供服務

美國血液技術

104.49
+1.801.75%
成交量:4.82萬
成交額:503.83萬
市值:47.49億
市盈率:50.97
高:106.98
開:106.98
低:102.86
收:102.69
52周最高:109.57
52周最低:47.32
股本:4,544.60萬
流通股本:4,459.72萬
量比:2.06
換手率:0.11%
股息:- -
股息率:- -
每股收益(TTM):2.05
每股收益(LYR):2.05
淨資產收益率:11.20%
總資產收益率:6.60%
市淨率:5.67
市盈率(LYR):50.97

資料載入中...

2020/05/20

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/04/17

重要事件披露

8-K - Current report
2020/04/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, item 5.02
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

重要事件披露

Current report, items 2.02 and 9.01
2020/01/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/14

重要事件披露

Current report, items 1.02, 7.01, and 9.01
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/01

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/01

重要事件披露

Current report, items 2.02 and 9.01
2019/10/29

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/10/29

持股變動聲明

Statement of changes in beneficial ownership of securities